FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Eris Lifesciences IPO and Tejas Networks IPO.
Eris Lifesciences IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Tejas Networks IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Eris Lifesciences IPO | Tejas Networks IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Axis Capital Limited Citigroup Global Markets India Private Limited Credit Suisse Securities (India) Private Limited |
Axis Capital Limited Citigroup Global Markets India Private Limited Edelweiss Financial Services Ltd Nomura Financial Advisory And Securities (India) Pvt Ltd |
Registrar | Link Intime India Private Ltd | Link Intime India Private Ltd |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | ||
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Eris Lifesciences IPO is up to ₹1,741.16 Cr whereas the issue size of the Tejas Networks IPO is up to ₹776.69 Cr. The final issue price of Eris Lifesciences IPO is ₹603.00 per share and of Tejas Networks IPO is ₹257.00 per share.
Eris Lifesciences IPO | Tejas Networks IPO | |
---|---|---|
Face Value | ₹1 per share | ₹10 per share |
Issue Price (Lower) | ₹600.00 per share | ₹250.00 per share |
Issue Price (Upper) | ₹603.00 per share | ₹257.00 per share |
Issue Price (Final) | ₹603.00 per share | ₹257.00 per share |
Discount (Retail) | ||
Discount (Employee) | ₹60.00 per share | |
Market Lot Size | 24 shares | 55 shares |
Fresh Issue Size | ||
Fresh Issue Size (Amount) | up to ₹450.00 Cr | |
OFS Issue Size | 2,88,75,000 shares | 1,27,11,605 shares |
OFS Issue Size (Amount) | ||
Issue Size Total | 2,88,75,000 shares | 3,02,21,332 shares |
Issue Size Total (Amount) | up to ₹1,741.16 Cr | up to ₹776.69 Cr |
Eris Lifesciences IPO opens on Jun 16, 2017, while Tejas Networks IPO opens on Jun 14, 2017. The closing date of Eris Lifesciences IPO and Tejas Networks IPO is Jun 20, 2017, and Jun 16, 2017, respectively.
Eris Lifesciences IPO | Tejas Networks IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | Jun 16, 2017 | Jun 14, 2017 |
Issue Close | Jun 20, 2017 | Jun 16, 2017 |
Basis Of Allotment (Tentative) | Jun 23, 2017 | Jun 21, 2017 |
Initiation of Refunds (Tentative) | Jun 27, 2017 | Jun 22, 2017 |
Credit of Share (Tentative) | Jun 28, 2017 | Jun 23, 2017 |
Listing date (Tentative) | Jun 29, 2017 | Jun 27, 2017 |
Anchor Lockin End date 1 | Jul 23, 2017 | Jul 21, 2017 |
Anchor Lockin End date 2 | Sep 21, 2017 | Sep 19, 2017 |
Eris Lifesciences IPO P/E ratio is , as compared to Tejas Networks IPO P/E ratio of .
Eris Lifesciences IPO | Tejas Networks IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW |
In the Eris Lifesciences IPO retail investors (RII) are offered 28,72,500 shares while in Tejas Networks IPO retail investors are offered 28,72,500 shares. Qualified institutional buyers (QIB) are offered 86,17,500 shares in Eris Lifesciences IPO and 94,34,105 shares in Tejas Networks IPO.
Eris Lifesciences IPO | Tejas Networks IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | ||
QIB | 86,17,500 shares | 94,34,105 shares |
NII | 43,08,750 shares | 46,06,740 shares |
RII | 28,72,500 shares | 30,71,160 shares |
Employee | 1,50,000 shares | |
Others | ||
Total | 1,59,48,750 shares | 1,71,12,005 shares |
Eris Lifesciences IPO subscribed 3.29x in total, whereas Tejas Networks IPO subscribed 1.88x.
Eris Lifesciences IPO | Tejas Networks IPO | |
---|---|---|
QIB (times) | 4.68x | 2.16x |
NII (times) | 0.45x | 0.48x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 3.51x | 3.10x |
Employee (times) | 0.86x | |
Other (times) | ||
Total (times) | 3.29x | 1.88x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|